Kamada Ltd. — Report Publication Announcement 2021

Nov 22, 2021

_________ false

����� ��"�	2 379
KAMADA LTD
Corporation no: 511524605	12585
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C001 ( Public )		Reported via MAGNA:	22/11/2021
	www.isa.gov.il			www.tase.co.il				Reference:	2021-02-100210	Time of broadcast: 13:54 13:54

---

Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onKamada Reports Third Quarter and First Nine Months of 2021 Financial Results, and Strategic Transformational Acquisition of a Portfolio of Four FDA-Approved Plasma-Derived Hyperimmune Commercial Products

ea149966-6k_kamadaltdEDGAR7_Bannerless_isa.pdf

Link to filing on foreign stock exchange (optional): _________

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: TASE	Date of revision of form structure: 19/10/2021
Address: Holtzman 2 4081 , Rehovot 7670402   ISRAEL , Tel: 08-9406472 , Fax: 08-9406473
E-mail address: liorf@kamada.com   Company site: www.kamada.com
Previous names of reporting entity:
Name of the Signatory: Fhima Lior Position of Signatory in the reporting corporation: Director of Finance Name of Employer Company:
Address: Haim holtzman 2 , Rehovot 7670402 Telephone: 08-9913168 Facsimile: 08-9912083 E-mail: liorf@kamada.com 1